Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

February 29, 2012

Conditions
Cancer of the Cervix
Interventions
DRUG

Cetuximab

monotherapy (day 1), then weekly thereafter along with radiation. dose is at 200mg/m2.

Trial Locations (2)

22908

RECRUITING

University of Virginia Cancer Center, Charlottesville

63110

SUSPENDED

Washinton University School of Medicine, St Louis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Washington University School of Medicine

OTHER

lead

University of Virginia

OTHER